Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Total Non-Current Liabilities: 2013-2018

Historic Total Non-Current Liabilities for Armata Pharmaceuticals (ARMP) over the last 5 years, with Sep 2018 value amounting to $3.6 million.

  • Armata Pharmaceuticals' Total Non-Current Liabilities fell 0.33% to $3.6 million in Q3 2018 from the same period last year, while for Sep 2018 it was $3.6 million, marking a year-over-year decrease of 0.33%. This contributed to the annual value of $3.1 million for FY2017, which is 47.97% down from last year.
  • As of Q3 2018, Armata Pharmaceuticals' Total Non-Current Liabilities stood at $3.6 million, which was up 13.02% from $3.2 million recorded in Q2 2018.
  • Armata Pharmaceuticals' 5-year Total Non-Current Liabilities high stood at $69.5 million for Q1 2014, and its period low was $2.9 million during Q1 2018.
  • Moreover, its 3-year median value for Total Non-Current Liabilities was $4.9 million (2017), whereas its average is $4.6 million.
  • Within the past 5 years, the most significant YoY rise in Armata Pharmaceuticals' Total Non-Current Liabilities was 11.08% (2016), while the steepest drop was 76.66% (2016).
  • Quarterly analysis of 5 years shows Armata Pharmaceuticals' Total Non-Current Liabilities stood at $17.4 million in 2014, then plummeted by 68.96% to $5.4 million in 2015, then grew by 11.08% to $6.0 million in 2016, then slumped by 47.97% to $3.1 million in 2017, then decreased by 0.33% to $3.6 million in 2018.
  • Its last three reported values are $3.6 million in Q3 2018, $3.2 million for Q2 2018, and $2.9 million during Q1 2018.